ICD-10-CM Billable Code

D72.11

Hypereosinophilic syndrome [HES]

Clinical Classification Guidelines

Medical Intelligence & Overview

Hypereosinophilic syndrome (HES) is a rare disorder characterized by an overproduction of eosinophils, a type of white blood cell involved in the body's immune response. When eosinophils are present in abnormally high levels for extended periods, they can cause damage to various tissues and organs. The condition is classified under ICD-10 code D72.11, indicating its recognition as a specific hematological disorder. HES can affect individuals of any age, and early diagnosis and management are crucial to prevent serious complications.

Causes & Symptoms

Clinical Causes: Primary (clonal) causes such as eosinophil proliferation due to genetic mutations Secondary causes like parasitic infections, allergies, or certain cancers Idiopathic cases where no clear cause can be identified Autoimmune responses leading to increased eosinophil production

Key Symptoms: Persistent fatigue and weakness Fever and night sweats Unexplained weight loss Shortness of breath or wheezing Skin rashes or lesions Swelling or pain in the abdomen Persistent cough or chest discomfort Significant eosinophil levels seen in blood tests Organ-specific symptoms depending on affected tissues (e.g., heart, lungs, skin, nervous system)

Diagnostic & Treatment

Diagnosis Path: Diagnosis of HES involves a combination of blood tests, imaging, and sometimes tissue biopsies. Key components include: - Complete blood count (CBC) revealing high eosinophil levels - Bone marrow examination to assess eosinophil proliferation - Imaging studies (such as echocardiography or MRI) to evaluate organ damage - Exclusion of other potential causes of eosinophilia - Molecular testing to identify genetic mutations in some cases Clinicians use these assessments collectively to establish the diagnosis and determine the extent of organ involvement.

Treatment Protocols: Managing hypereosinophilic syndrome aims to reduce eosinophil levels and prevent organ damage. Typical approaches include: - Corticosteroids (like prednisone) to suppress eosinophil production - Cytotoxic drugs or immunosuppressants in resistant cases - Targeted therapies, such as tyrosine kinase inhibitors, especially in cases with specific genetic mutations - Treatment of underlying conditions if identified (e.g., parasitic infections) - Regular monitoring to assess eosinophil levels and organ function - Supportive care for symptom relief as needed The specific treatment plan depends on the severity of the disease, underlying cause, and organ systems involved.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is D72.11 a billable ICD-10 code?
Yes, D72.11 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report D72.11?
Clinical documentation must specify the nature of Hypereosinophilic syndrome [HES] and any associated comorbidities for accurate reporting.

Cite this Clinical Reference